clofibric acid has been researched along with Lipid Metabolism Disorders in 2 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
Lipid Metabolism Disorders: Pathological conditions resulting from abnormal anabolism or catabolism of lipids in the body.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steinhilber, D | 1 |
| Schubert-Zsilavecz, M | 1 |
| Kostner, KM | 1 |
| Kostner, GM | 1 |
2 reviews available for clofibric acid and Lipid Metabolism Disorders
| Article | Year |
|---|---|
[Molecular pharmacology and medicinal chemistry of fibrate].
Topics: Animals; Clofibric Acid; Humans; Hypolipidemic Agents; Lipid Metabolism Disorders; Peroxisome Prolif | 2007 |
[Fibrate in lipid metabolism disorders].
Topics: Animals; Atherosclerosis; Clofibric Acid; Diabetes Complications; Humans; Hypolipidemic Agents; Lipi | 2007 |